Endoscopic Submucosal Dissection Market Size, Share & Trends Analysis Report By Product (Gastroscopes & Colonoscopes), By Indication (Stomach Cancer), By End-use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030
Market Size & Trends
The global endoscopic submucosal dissection market size was estimated at USD 350.3 million in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030. The increasing prevalence of gastrointestinal cancers and other related disorders and advancements in endoscopic technology & instrumentation drive the demand for diagnostic and therapeutic procedures such as ESD. According to the World Cancer Research Fund International, stomach cancer is the fifth most common cancer worldwide, ranking fourth in men and seventh in women, with over 968,784 new cases in 2022, with China reporting the highest incidence at 358,672 cases. As esophageal, gastric, and colorectal cancer rates continue to rise globally, the need for advanced procedures, including ESD, becomes more persistent.
Furthermore, the aging population worldwide is a crucial factor boosting the demand for ESD. As the global population grows older, age-related gastrointestinal conditions, including cancers, are expected to rise. According to the American Cancer Society, gastric cancer, predominantly affects older individuals, with an average age of 68 when diagnosed, and 6 out of 10 diagnosed annually are 65 or older. Older patients often have comorbidities that make traditional surgery riskier, thereby increasing the preference for less invasive options including ESD.
The development of high-definition endoscopes improved electrosurgical knives, and enhanced imaging techniques have significantly increased the precision and safety of ESD procedures. These technological innovations have improved the efficacy of the treatment and expanded the indications for ESD, allowing it to be used for a broader range of lesions. Moreover, integrating artificial intelligence and machine learning in endoscopic procedures enhances diagnostic accuracy and procedural outcomes, further propelling market growth. For instance, in September 2020, Olympus Corporation launched an AI-powered colon endoscopy platform, ENDO-AID, that allows real-time display of detected suspicious lesions.
The growing awareness and training programs for healthcare professionals in ESD techniques also contribute to market expansion. The proficiency of gastroenterologists and surgeons in ESD has been increasing, enhancing both the reach and feasibility of this advanced procedure, particularly in areas that previously had limited access to such treatments. Various medical societies and institutions offer specialized training and certification programs, which are instrumental in disseminating knowledge and expertise in ESD. For instance, in April 2024, FUJIFILM Healthcare Europe GmbH introduced EndoGel, an innovative training model designed for performing Peroral Endoscopic Myotomy (POEM) and Endoscopic Submucosal Dissection (ESD) procedures. This simulator comes in two versions and accurately replicates the texture of human tissue involved in these complex procedures, offering clinicians a realistic training experience. It is also compatible with a range of medical devices typically used in POEM and ESD procedures, including high-frequency devices. It is specifically engineered to be cost-effective for endoscopy professionals and healthcare institutions, aiming to enhance proficiency and patient outcomes through realistic simulation training.
Global Endoscopic Submucosal Dissection Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the endoscopic submucosal dissection (ESD) market based on product, indication, end-use, and regions.
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Gastroscopes and Colonoscopes
- Knives
- Injection Agents
- Tissue Retractors
- Graspers/ Clips
- Other Products
- Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Stomach Cancer
- Colon Cancer
- Esophageal Cancer
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Outpatient Facilities
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Indication
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Indication Outlook
- 2.2.3. End Use Outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Endoscopic Submucosal Dissection Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Industry Analysis - Porter’s Five Forces
- 3.2.3.1. Bargaining power of the suppliers
- 3.2.3.2. Bargaining power of the buyers
- 3.2.3.3. Threats of substitution
- 3.2.3.4. Threats from new entrants
- 3.2.3.5. Competitive rivalry
- 3.2.4. PESTEL Analysis
- 3.2.4.1. Political landscape
- 3.2.4.2. Economic and Social landscape
- 3.2.4.3. Technological landscape
- Chapter 4. Endoscopic Submucosal Dissection Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Endoscopic Submucosal Dissection Market: Product Movement Analysis, USD Million, 2023 & 2030
- 4.2.1. Gastroscopes and Colonoscopes
- 4.2.1.1. Gastroscopes and Colonoscopes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Knives
- 4.2.2.1. Knives Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.3. Injection Agents
- 4.2.3.1. Injection Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.4. Tissue Retractors
- 4.2.4.1. Tissue Retractors Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.5. Graspers/ Clips
- 4.2.5.1. Graspers/ Clips Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.6. Other Products
- 4.2.6.1. Other Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Endoscopic Submucosal Dissection Market: Indication Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Endoscopic Submucosal Dissection Market: Indication Movement Analysis, USD Million, 2023 & 2030
- 5.2.1. Stomach Cancer
- 5.2.1.1. Stomach Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Colon Cancer
- 5.2.2.1. Colon Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.3. Esophageal Cancer
- 5.2.3.1. Esophageal Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Endoscopic Submucosal Dissection Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Endoscopic Submucosal Dissection Market: End Use Movement Analysis, USD Million, 2023 & 2030
- 6.2.1. Hospitals
- 6.2.1.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Outpatient Facilities
- 6.2.2.1. Outpatient Facilities Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Endoscopic Submucosal Dissection Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. France market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework/ reimbursement structure
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework/ reimbursement structure
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework/ reimbursement structure
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework/ reimbursement structure
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. China market estimates and forecasts 2018 to 2030, (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. India market estimates and forecasts 2018 to 2030, (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework/ reimbursement structure
- 7.7.6.3. Competitive scenario
- 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework/ reimbursement structure
- 7.8.1.3. Competitive scenario
- 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework/ reimbursement structure
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Regulatory framework/ reimbursement structure
- 7.9.1.3. Competitive scenario
- 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework/ reimbursement structure
- 7.9.2.3. Competitive scenario
- 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework/ reimbursement structure
- 7.9.3.3. Competitive scenario
- 7.9.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework/ reimbursement structure
- 7.9.4.3. Competitive scenario
- 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Market Position Analysis, 2023
- 8.4. Company Profiles
- 8.4.1. Olympus Corporation
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Boston Scientific Corporation
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. FUJIFILM Holdings Corporation
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Creo Medical
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Medtronic PLC
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. HOYA Corporation
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. KARL STORZ SE & Co. KG
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. CONMED Corporation
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Steris PLC
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Taewoong Medical
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. Micro-tech Endoscopy
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Product benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. Cook Group
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Product benchmarking
- 8.4.12.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook